Sulfuric Acid

Sulfuric Acid

SCHEMBL31228587

C=CC(=O)NC(C)N.C=CC(=O)NC(C)N.O=S(=O)(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CALCRLCHRM1CHRM2CHRM3F2RMAOAMAOBMAP2K1MAP2K2NTRK1NTRK2NTRK3OPRD1OPRK1OPRM1P2RY12PKLRSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASLC18A2SLC6A2SLC6A3TLR7TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8dacAdacBdacCfolAftsImrcAmrcBmrdApolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmB1rpmB2rpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmHrpmIrpmJrpmJ2rpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsR1rpsR2rpsSrpsTrpsUrpsZykgMykgO

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TGM2 P21980 1/20 0.33
ZDHHC20 Q5W0Z9 1/20 0.33
ZDHHC2 Q9UIJ5 1/20 0.33
TP53 P04637 1/20 0.31
ACACB O00763 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8442797 0.91
Hydrochloric Acid SCHEMBL28468704 0.89 TSHR (0.62) TSHRCYP2C19ALDH1A1MAPK1TDP1
Hydrochloric Acid SCHEMBL4442955 0.89
Sulfuric Acid SCHEMBL28826242 0.84 TSHR (0.52) TSHRCYP2C19ALDH1A1MAPK1TDP1
Sulfuric Acid SCHEMBL10754253 0.83 TSHR (0.82) TSHRCYP2C19ALDH1A1MAPK1TDP1
SCHEMBL27866179 0.78 TSHR (0.82) TSHRCYP2C19ALDH1A1MAPK1TDP1
Methylamine SCHEMBL11695431 0.78 TSHR (0.54) TSHRCYP2C19ALDH1A1MAPK1TDP1
SCHEMBL454340 0.77 TSHR (0.58) TSHRCYP2C19ALDH1A1MAPK1TDP1
Sulfuric Acid SCHEMBL6253912 0.76 TSHR (0.52) TSHRALDH1A1MAPK1TDP1ZDHHC20
Sulfuric Acid SCHEMBL28949838 0.76 TSHR (0.52) TSHRCYP2C19ALDH1A1MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12618000-B2 Friction reduction of acidic treatment fluids HALLIBURTON ENERGY SERVICES, INC. (US) 2026-05-05 US disclosed
US-20260071533-A1 TREATMENT FLUID SELECTION HALLIBURTON ENERGY SERVICES, INC. (US) 2026-03-12 US disclosed
US-20250051635-A1 FRICTION REDUCTION OF ACIDIC TREATMENT FLUIDS HALLIBURTON ENERGY SERVICES, INC. (US) 2025-02-13 US disclosed
WO-2025006003-A1 FRICTION REDUCTION OF ACIDIC TREATMENT FLUIDS HALLIBURTON ENERGY SERVICES, INC. (US) 2025-01-02 WO disclosed
US-12139667-B1 Friction reduction of acidic treatment fluids HALLIBURTON ENERGY SERVICES, INC. (US) 2024-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071533-A1 TREATMENT FLUID SELECTION PLG, SOST, CSTB TSHR 1255/4885CYP2C19 2176/4885ALDH1A1 3827/4885
US-12618000-B2 Friction reduction of acidic treatment fluids GFER, FGB, NSF TSHR 1564/4885CYP2C19 4142/4885ALDH1A1 3043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.